TRACI JONES: Open Payments
NPI 1881044246 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 56 payments from 12 companies in 2025. Trend: 2023 $1,807 · 2024 $1,823 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $448 |
| ABBVIE INC. | 13 | $235 |
| Organon LLC | 4 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $155 |
| UCB, Inc. | 9 | $153 |
| Botanix SB Inc | 6 | $114 |
| LEO Pharma Inc. | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
Products named: DUPIXENT, VTAMA, SKYRIZI, Bimzelx, SOFDRA, Rhapsido, RINVOQ, ADBRY.
Industry payments across GA — which companies pay providers there.
